UNK_LASSO
Report
- Report Number
- 2029046-2019-03375
- Event Type
- Injury
- Date Received
- July 1, 2019
- Date of Event
- January 31, 2011
- Report Date
- June 10, 2019
- Manufacturer
- BIOSENSE WEBSTER INC
- Product Code
- DRF
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS
- Reporter Occupation
- PHYSICIAN
Narratives
NO DEVICE WAS RECEIVED FOR ANALYSIS AT THE TIME OF SUBMISSION OF THE INITIAL 3500A. SINCE THE PRODUCT WAS NOT RETURNED FOR ANALYSIS, NO PRODUCT FAILURE ANALYSIS CAN BE CONDUCTED, AND NO DETERMINATION OF POSSIBLE CONTRIBUTING FACTORS COULD BE MADE. DEVICE HISTORY RECORD (DHR) REVIEW CANNOT BE CONDUCTED BECAUSE THE LOT NUMBER WAS PROVIDED BY THE CUSTOMER. MANUFACTURER'S REF. NO: (B)(4). BIOSENSE WEBSTER MANUFACTURER'S REPORT NUMBERS: 2029046-2019-03373, 2029046-2019-03374, ARE RELATED TO THE SAME INCIDENT.
THIS COMPLAINT IS FROM A LITERATURE SOURCE. THE FOLLOWING COMPLICATIONS WERE REPORTED IN THIS PUBLICATION: 1 PATIENT UNDERWENT CATHETER ABLATION OF ATRIAL FIBRILLATION AND SUFFERED PARALYTIC ILEUS (GASTROPARESIS). NO ADDITIONAL DETAILS WERE PROVIDED. MULTIPLE REQUESTS FOR CLARIFICATION HAVE BEEN SENT TO THE CORRESPONDING AUTHOR, BUT NO ADDITIONAL DETAILS WERE PROVIDED AT THIS TIME. IF ADDITIONAL DETAILS WILL BE PROVIDED THIS REPORT WILL BE UPDATED ACCORDINGLY. THERE ARE 0 DEATH EVENTS AND 0 DEVICE MALFUNCTIONS REPORTED IN THIS PUBLICATION. MODEL AND CATALOG NUMBER ARE NOT AVAILABLE, BUT THE SUSPECTED DEVICE IS LASSO. OTHER BIOSENSE WEBSTER DEVICES THAT WERE ALSO USED IN THIS STUDY: NONE. NON-BIOSENSE WEBSTER DEVICES THAT WERE ALSO USED IN THIS STUDY: NAVX SYSTEM (ST. JUDE MEDICAL, INC.), DUO-DECAPOLAR (ST. JUDE MEDICAL, INC., MINNETONKA, MN, USA) AND DECAPOLAR (BARD ELECTROPHYSIOLOGY, INC., LOWELL, MA, USA), (FAST-CATHTM SWARTZTM),ST JUDE MEDICAL, AF DIVISION, MINNETONKA, MN, USA). PUBLICATION DETAILS: TITLE: COMPARISON BETWEEN LINEAR AND FOCAL ABLATION OF COMPLEX FRACTIONATED ATRIAL ELECTROGRAMS IN PATIENTS WITH NON-PAROXYSMAL ATRIAL FIBRILLATION: A PROSPECTIVE RANDOMIZED TRIAL. OBJECTIVE: TO COMPARE CLINICAL OUTCOMES OF COMPLEX FRACTIONATED ATRIAL ELECTROGRAM (CFAE)-GUIDED FOCAL ABLATION (CFA) AND CFAE-GUIDED LINEAR ABLATION (CLA) IN PATIENTS WITH NON-PAROXYSMAL AF. METHODS: PATIENTS WERE ENROLLED BETWEEN JANUARY 2009 AND AUGUST 2011. 150 PATIENTS WITH NON-PAROXYSMAL AF INTO CFA AND CLA GROUPS IN A 1:1 RATIO. COMPLEX FRACTIONATED ATRIAL ELECTROGRAM DISTRIBUTION WAS EVALUATED USING AN AUTOMATED ALGORITHM OF A THREE-DIMENSIONAL MAPPING SYSTEM. AFTER PULMONARY VEIN ISOLATION (PVI), CFAE-GUIDED ABLATION WAS PERFORMED IN THE LEFT ATRIUM AND THEN IN THE RIGHT ATRIUM (RA).
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 544045 | UNK_LASSO | UNK | DRF | BIOSENSE WEBSTER INC |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 56 YR | Other |